The New York Times - 08 Oct 2020
The company said that doses of the unproven treatment would be available for 50000 patients. It's impossible to know whether it helped the president.
The Manila Times - 13 Nov 2024
Regeneron to Highlight Pioneering Pipeline Progress Across Multiple Modalities Spanning 10 Types of Blood Cancers and Disorders at ASH ...